Primary tabs
The list of publications is indicative and may not include all publications.
Albuminuria and cardiorenal risk..
Curr Opin Cardiol.
(2023).
Should we discontinue RAS-inhibitor therapy in patients with advanced CKD?.
Expert Opin Pharmacother.
(2023).
Measures of frequency and effect in clinical research..
Int Urol Nephrol.
(2023).
Which blood pressure threshold indicates a therapeutic benefit for patients with chronic kidney disease?.
Hypertens Res. 46(4), 890-892.
(2023).
Frailty, sarcopenia and diabetic kidney disease: where do we stand?.
Int Urol Nephrol. 55(5), 1173-1181.
(2023).
N-Acetylcysteine: more than preventing contrast-induced nephropathy in uremic patients-focus on the antioxidant and anti-inflammatory properties..
Int Urol Nephrol. 55(6), 1481-1492.
(2023).
Effects of a Combined Intradialytic Exercise Training Program on Functional Capacity and Body Composition in Kidney Transplant Candidates..
J Funct Morphol Kinesiol. 8(1),
(2023).
Effect of angiotensin-converting enzyme inhibitors or angiotensin receptor blockers on cardiovascular outcomes in dialysis patients: a systematic review and meta-analysis..
Nephrol Dial Transplant. 38(1), 203-211.
(2023).
Therapeutic Advances in Diabetic Kidney Disease..
Int J Mol Sci. 24(3),
(2023).
Combination therapy with an SGLT-2 inhibitor and finerenone in DKD: Are we there yet?.
Eur J Clin Invest. 53(2), e13864.
(2023).
Redox Systems Biology in Chronic Kidney Disease..
Oxid Med Cell Longev. 2023, 9864037.
(2023).
Effects of Sodium-Glucose Co-Transporter-2 Inhibitors on Markers of Vascular Damage..
J Pers Med. 13(3),
(2023).
The interaction of estimated glomerular filtration rate with circadian blood pressure variation: do not forget the impact of albuminuria..
J Hypertens. 40(7), 1432-1433.
(2022).
VItamin K In PEritonial DIAlysis (VIKIPEDIA): Rationale and study protocol for a randomized controlled trial..
PLoS One. 17(8), e0273102.
(2022).
Editorial for the Special Issue "Vitamin K in Chronic Disease and Human Health"..
Nutrients. 14(13),
(2022).
The effect of a 6-month intradialytic exercise program on hemodialysis adequacy and body composition: a randomized controlled trial..
Int Urol Nephrol. 54(11), 2983-2993.
(2022).
Hypertension in Dialysis Patients: Diagnostic Approaches and Evaluation of Epidemiology..
Diagnostics (Basel). 12(12),
(2022).
Dapagliflozin Prevents High-Glucose-Induced Cellular Senescence in Renal Tubular Epithelial Cells..
Int J Mol Sci. 23(24),
(2022).
Prevalence, recurrence and seasonal variation of hyperkalemia among patients on hemodialysis..
Int Urol Nephrol. 54(9), 2327-2334.
(2022).